Regencell Bioscience Holdings Limited RGC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.19M | 14.19M | 2.36M | 2.36M | 4.90M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 30.70K | 30.70K | -- | -- | 5.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.22M | 14.22M | 2.36M | 2.36M | 4.90M |
|
|
|||||
| Total Current Assets | 14.22M | 14.22M | 2.36M | 2.36M | 4.90M |
| Net Property, Plant & Equipment | 430.70K | 430.70K | 562.70K | 562.70K | 759.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.70K | 75.70K | 93.40K | 93.40K | 93.00K |
| Total Assets | 14.73M | 14.73M | 3.01M | 3.01M | 5.76M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 1.07M | 1.07M | 1.41M | 1.41M | 348.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 236.30K | 236.30K | 258.10K | 258.10K | 312.80K |
| Total Finance Division Other Current Liabilities | 10.80K | 10.80K | 100.00 | 100.00 | 2.50K |
| Total Other Current Liabilities | 10.80K | 10.80K | 100.00 | 100.00 | 2.50K |
| Total Current Liabilities | 1.32M | 1.32M | 1.67M | 1.67M | 663.70K |
|
|
|||||
| Total Current Liabilities | 1.32M | 1.32M | 1.67M | 1.67M | 663.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 59.50K | 59.50K | 128.20K | 128.20K | 231.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.38M | 1.38M | 1.79M | 1.79M | 895.30K |
|
|
|||||
| Common Stock & APIC | 50.30M | 50.30M | 31.76M | 31.76M | 30.13M |
| Retained Earnings | -36.90M | -36.90M | -30.52M | -30.52M | -25.20M |
| Treasury Stock & Other | -45.30K | -45.30K | -24.70K | -24.70K | -64.80K |
| Total Common Equity | 13.35M | 13.35M | 1.22M | 1.22M | 4.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.35M | 13.35M | 1.22M | 1.22M | 4.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.35M | 13.35M | 1.22M | 1.22M | 4.86M |
|
|
|||||